Adjuvant and Neoadjuvant Therapy, Treatment for Advanced Disease, and Genetic Considerations for Adrenocortical Carcinoma: An Update from the SSO Endocrine and Head and Neck Disease Site Working Group-Reference-Cited by-同舟云学术

Adjuvant and Neoadjuvant Therapy, Treatment for Advanced Disease, and Genetic Considerations for Adrenocortical Carcinoma: An Update from the SSO Endocrine and Head and Neck Disease Site Working Group

Published:2018-09-14 Issue:12 Volume:25 Page:3453-3459
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Dickson Paxton V.,Kim Lawrence,Yen Tina W. F.,Yang Anthony,Grubbs Elizabeth G.,Patel Dhavel,Solórzano Carmen C.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/article/10.1245/s10434-018-6750-9/fulltext.html

Reference49 articles.

1. Terzolo M, Angeli A, Fassnacht M, et al. Adjuvant mitotane treatment for adrenocortical carcinoma. N Engl J Med. 2007;356(23):2372–2380.

2. Berruti A, Grisanti S, Pulzer A, et al. Long-term outcomes of adjuvant mitotane therapy in patients with radically resected adrenocortical carcinoma. J Clin Endocrinol Metab. 2017;102(4):1358–1365.

3. Else T, Williams AR, Sabolch A, Jolly S, Miller BS, Hammer GD. Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma. J Clin Endocrinol Metab. 2014;99(2):455–461.

4. Grubbs EG, Callender GG, Xing Y, et al. Recurrence of adrenal cortical carcinoma following resection: surgery alone can achieve results equal to surgery plus mitotane. Ann Surg Oncol. 2010;17(1):263–270.

5. Postlewait LM, Ethun CG, Tran TB, et al. Outcomes of adjuvant mitotane after resection of adrenocortical carcinoma: a 13-institution study by the US adrenocortical carcinoma group. J Am Coll Surg. 2016;222(4):480–490.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges and controversies in adrenal surgery: A practical approach;Current Problems in Surgery;2023-09

2. Interplay between Immune Cell Infiltration and Tumor Histological Subtype: A Case of Adrenocortical Cancer;Cancers;2022-10-28

3. Operative approach and case volume are associated with negative resection margins for adrenocortical carcinoma;Surgical Endoscopy;2022-03-04

4. Factors Associated with Non–Operative Management of Resectable Adrenocortical Carcinoma;Journal of Surgical Research;2021-11

5. The Immunotherapy Landscape in Adrenocortical Cancer;Cancers;2021-05-28